You are here:
22.05.2019 To 24.05.2019
How to publish a research paper in a major biomedical journal, 22.05. - 24.05.2019
Intensive Short Course
University of Zagreb – School of Medicine, Andrija Štampar School of Public Health and Charité – Universitätsmedizin Berlin, Institute of Public Health in affiliation with the Berlin School of Public Health are organising a postgraduate continuing medical education course: "How to publish a research paper in a major biomedical journal".
05.04.2019 To 05.04.2019
Information event: Master programs at Berlin School of Public Health, April 5th, 2019
The Berlin School of Public Health will inform about the consecutive Master's program in Public Health and the continuing Master's programs in Public Health and Epidemiology on Friday, April 5, 2019 from 16:00 - 18:00h. Registration is not necessary.
17.10.2018 To 17.10.2018
IPH Lecture - Maria Glymour, ScD, MS, Professor at UCSF School of Medicine
“Are we ready for a biomarker-only based diagnostic criterion for research in Alzheimer's Disease?”
Maria Glymour, ScD, MS, Professor at the Department of Epidemiology and Biostatistics, UCSF School of Medicine, will present “Are we ready for a biomarker-only based diagnostic criterion for research in Alzheimer's Disease?”
20.08.2018 To 24.08.2018
Advanced Epidemiologic Methods: Causal Research and prediction modelling
Intensive Short Course
29.06.2018 To 29.06.2018
Urban Health: Concepts, consequences and challenges for health in large cities
Whether people are or remain healthy, is influenced by both their living circumstances and environment. In this conference, experts from France and Germany will explain major health threats for residents of urban environment, but also share visions and concrete prototypes for a healthier life in large cities. The conference is organized by the Centre Virchow-Villermé for Public Health Paris-Berlin and the science department of the French Embassy in Berlin.
17.04.2018 To 17.04.2018
IPH-Lecture by Harvard Professor Julie Buring: "The Complexity of Clinical Trials in the Prevention of Cardiovascular Disease: An Investigator's Perspective"
"The Complexity of Clinical Trials in the Prevention of Cardiovascular Disease: An Investigator's Perspective" Randomized clinical trials are more logistically difficult, more expensive, and need to consider more ethical issues than any other epidemiologic design strategy – yet if well designed and conducted, randomized trials can provide the highest level of assurance about the effect of the intervention itself. This lecture will address the complexity of randomized trials of prevention from an investigator’s standpoint, in the context of the evaluation of aspirin in the primary prevention of cardiovascular disease.